Ab18 TVD-Ig/αTfR

N/A

Report date: 2022/11/16 17:18:56

Base Information

Drug NameAb18 TVD-Ig/αTfR
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTriggering receptor expressed on myeloid cells 2 stimulantsTransferrin receptor protein 1 stimulants
TargetsTriggering receptor expressed on myeloid cells 2Transferrin receptor protein 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Texas Health Science Center At Houston
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Texas Health Science Center At Houston
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A